FDA approves MimyX cream for the treatment of atopic dermatitis

Journal of Drugs in Dermatology, Jan, 2006

The FDA recently approved Stiefel Laboratories' MimyX cream for the treatment of atopic dermatitis. Unlike traditional topical treatments for atopic dermatitis which target the inflammatory pathway, MimyX cream works by restoring the natural components of the stratum corneum and re-establishing barrier function of the outer layers of the epidermis.

MimyX cream is approved for patients of all ages and provides physicians with a nonsteroidal alternative to treating atopic dermatitis. It is also indicated for allergic contact dermatitis and radiation dermatitis.